Drug Profile
Olumacostat glasaretil - Dermira
Alternative Names: DRM 01; DRM-01B; VAL-001Latest Information Update: 26 Feb 2020
Price :
$50
*
At a glance
- Originator QLT
- Developer Dermira
- Class Antiacnes; Furans; Small molecules
- Mechanism of Action Acetyl-CoA carboxylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Acne vulgaris
Most Recent Events
- 20 Feb 2020 Dermira has been acquired by Eli Lilly and Company
- 08 Jun 2018 Discontinued - Phase-II for Acne vulgaris in Canada (Topical)
- 08 Jun 2018 Discontinued - Phase-III for Acne vulgaris (In adolescents, In children, In the elderly, In adults) in Australia, Canada, USA (Topical)